Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.

导出 OA

翻译打印收藏纠错

作者： Celso,Arango ^[1] ; Daisy,Ng-Mak ^[2] ; Elaine,Finn ^[3] ; Aidan,Byrne ^[3] ; Antony,Loebel ^[4]

作者单位： Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón. IiSGM, School of Medicine, Universidad Complutense, CIBERSAM. Av. Séneca 2, 28040, Madrid, Spain. ^[1] Sunovion Pharmaceuticals Inc, 84 Waterford Drive, Marlborough, MA, 01752, USA. Daisy.Ng-Mak@Sunovion.com. ^[2] IQVIA, 210 Pentonville Rd, London, N1 9JY, UK. ^[3] Sunovion Pharmaceuticals Inc, One Bridge Plaza North, Suite 510, Fort Lee, NJ, 07024, USA. ^[4]

关键词 Adolescent Body weight changes Lurasidone Network meta-analysis Schizophrenia

主题词青少年(Adolescent);抗精神病药(Antipsychotic Agents);女(雌)性(Female);人类(Humans);男(雄)性(Male);精神分裂症(Schizophrenia)

DOI 10.1007/s00787-019-01425-2

PMID 31758359

发布时间 2020-10-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交